• Events Calendar
  • Drug Discovery
    • Targets & Screening
    • Pre-Clinical & Translational Development
    • Drug Design & Medical Chemistry
    • AI & Automation
  • Drug Development
    • Large Molecule Formation
    • Large Molecule Delivery
    • Small Molecule Formulation
    • Small Molecule Delivery
    • RNA Design & Delivery
  • Therapeutics
    • Neuro & Neuroimmunology
    • ADC-Based
    • News
    • Market Insight
    • Thought Leadership
    • Technology Spotlight
Register Sign In
  • Events Calendar
  • Drug Discovery
      Targets & Screening
      Pre-Clinical & Translational Development
      Drug Design & Medical Chemistry
      AI & Automation
  • Drug Development
      Large Molecule Formation
      Large Molecule Delivery
      Small Molecule Formulation
      Small Molecule Delivery
      RNA Design & Delivery
  • Therapeutics
      Neuro & Neuroimmunology
      ADC-Based
  • Format
      News
      Market Insight
      Thought Leadership
      Technology Spotlight
    Search
Sign In
Thought Leadership Drug Discovery |

Interview with Synthelis

On-Demand
July 30, 2025
|
11:00 UK Time
|
Event lasts 20m
Vincent Poher

Vincent Poher

Chief Executive Officer

Synthelis

Format: 17 Minute Interview

Register free to attend thought leadership

Do you have a question you’d like Vincent Poher to answer during the session?

Register and ask
Related posts
Interview with MyxoTech

Interview with MyxoTech

Peter Sullivan MyxoTech
Drug Discovery
Aug, 2025
Interview with BioOrbit

Interview with BioOrbit

Sam Moorcroft BioOrbit
Drug Discovery
Aug, 2025
Interview with Cortex Discovery

Interview with Cortex Discovery

Cedric Beny Cortex Discovery
Vladimir Chorošajev Cortex Discovery
Drug Discovery
Aug, 2025
Interview with Synthelis

Interview with Synthelis

Vincent Poher Synthelis
Drug Discovery
Aug, 2025
Interview with SynSilico

Interview with SynSilico

Oliver May SynSilico
Drug Discovery
Aug, 2025
Upcoming events
18
Sep
Unlocking the Brain: Innovations in CNS Drug Discovery and Neurodegenerative Treatment

Online

Join Emma Mead the Chief Scientific Officer of Alzheimer's Research UK, Oxford Drug Discovery Institute to discuss the latest innovations in CNS drug delivery and neurodegenerative therapeutics.

02
Oct
Formulation & Delivery US 2025

In-Person

Driving the development of novel and alternative therapies through safe, effective and precise formulation and delivery solutions.

Register for free to view

  • Quickly grasp the key takeaways from cutting-edge biomed research with our bite-sized 5-minute video summaries, before diving into the full presentations from leaders in the industry.

  • From cutting-edge discoveries to real-world applications, see how new research can impact your work, from the lab to commercialisation.

  • Join a community of next-gen scientists, academics and researchers, stay connected, and engage with the latest innovations shaping the future of biomedicine.

Register Free

Already registered? Sign In.

  • Events
    About Us
    Contact Us
    FAQ
    Privacy Policy
    Terms of Use
    Cookie Policy
  • Drug Discovery
    Drug Development
    Therapeutics
  • Discovery & Development
    NextGen Biomed
    Precision Medicine
    Oxford Global
© 2025 Oxford Global Ltd. All rights reserved.
Designed & built by Standfirst

You're just a click away

To access our site, please accept the Terms of Use - our full terms of use are available below.
Full Terms of Use

By rejecting you won't be able to progress to the LifeScienceXchange platform.